| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $95.55M | $63.27M | $53.56M | $56.44M | $71.21M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$95.55M | -$63.27M | -$53.56M | -$56.44M | -$71.21M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | $21.31B | $2.17B | -$128.98M | -$18.02M | -$2.11B |
| EPS (basic) | 40.9000 | 4.4200 | -0.2600 | -0.0300 | -3.4600 |
| EPS (diluted) | – | – | – | – | – |
| Shares (diluted) | – | – | – | – | – |